BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36078143)

  • 21. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
    Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
    Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
    Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
    Radiat Res; 2012 Jan; 177(1):59-68. PubMed ID: 21980958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels.
    Molinari AJ; Thorp SI; Portu AM; Saint Martin G; Pozzi EC; Heber EM; Bortolussi S; Itoiz ME; Aromando RF; Monti Hughes A; Garabalino MA; Altieri S; Trivillin VA; Schwint AE
    Acta Oncol; 2015 Jan; 54(1):99-106. PubMed ID: 24960584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M
    Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
    Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
    Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
    Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
    Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
    J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
    Bergenheim AT; Capala J; Roslin M; Henriksson R
    J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
    Coderre JA; Elowitz EH; Chadha M; Bergland R; Capala J; Joel DD; Liu HB; Slatkin DN; Chanana AD
    J Neurooncol; 1997 May; 33(1-2):141-52. PubMed ID: 9151231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
    Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice.
    Ono K; Masunaga S; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):431-6. PubMed ID: 10030272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
    Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
    Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer.
    Trivillin VA; Heber EM; Itoiz ME; Nigg D; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Appl Radiat Isot; 2004 Nov; 61(5):939-45. PubMed ID: 15308172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
    Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
    Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.
    Lin YC; Hwang JJ; Wang SJ; Yang BH; Chang CW; Hsiao MC; Chou FI
    Anticancer Res; 2012 Jul; 32(7):2657-64. PubMed ID: 22753723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Boron neutron capture therapy (BNCT) for the treatment of liver metastases: biodistribution studies of boron compounds in an experimental model.
    Garabalino MA; Monti Hughes A; Molinari AJ; Heber EM; Pozzi EC; Cardoso JE; Colombo LL; Nievas S; Nigg DW; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Radiat Environ Biophys; 2011 Mar; 50(1):199-207. PubMed ID: 21132507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.